Complement factor C3, the central protein of the complement system, was found to be phosphorylated both in EDTA-and heparin-anticoagulated whole blood and in coagulating blood. Complement S protein (vitronectin) was also found to be phosphorylated under these conditions. Further, purified C3 was found to be a phosphoprotein in vivo, containing 0.15 mol of alkali-labile phosphate/mol of protein. The [4] [5] [6] [7] , and an ATP concentration of 2OftM has been reported in human serum during coagulation [8] .
INTRODUCTION
Fibrinogen was the first plasma phosphoprotein to be identified [1] , and the function of its phosphate groups remains unclear 25 years later. Recently complement S protein (vitronectin) has also been found -to be a phosphoprotein [2] that can be phosphorylated by a cyclic AMP-dependent protein kinase secreted by thrombin-activated platelets [3] . Furthermore, a number of other reports have appeared on plasma and extracellular protein kinases [4] [5] [6] [7] , and an ATP concentration of 2OftM has been reported in human serum during coagulation [8] .
Intracellularly, protein phosphorylation is a control mechanism that is found to act on regulatory enzymes in metabolic pathways. In blood, the complement cascade can be activated by two independent pathways, both of which converge on C3, making C3 a likely candidate for phosphorylation if regulatory phosphorylation occurs in the blood.
Complement activation by the classical pathway occurs when antibodies react with foreign antigens and involves complement factors C1, C4 and C2, resulting in the proteolytic conversion of C3 into C3a, an anaphylatoxin, and C3b. The alternative pathway is antibody-independent and is activated by bacterial and fungal cellwall components. Here, Factors D and B convert C3 into C3a and C3b. C3b binds to the convertase, altering its specificity so that it activates the remaining factors C5-C9 of the membrane attack complex, causing lysis of the target bacterium (for a review see [9] Determination of the alkali-labile phosphate content of C3 C3 was prepared rapidly from 10-15 ml of EDTAanticoagulated plasma by chromatography on a 20 ml DEAE-Sephacel column equilibrated with 10 mMTris/HCl buffer, pH 7.4, containing 32 mM-6-aminohexanoic acid, 6.4 mM-EDTA and 6.4 mM-benzamidine. A 0-300 mM-NaCl gradient in the same buffer was used to elute C3. The C3 pool, dialysed against four changes of 50 mM-Tris/HCl buffer, pH 7.4, containing 0.2 M-NaCl, was found to be more than 95 % pure by SDS/polyacrylamide-gel electrophoresis. Rapid purification of C3 (48 h) was necessary for the detection of protein-bound phosphate. Alkali-labile phosphate was not detectable in C3 from large-scale preparations taking several weeks, and this is believed to be due to phosphatase activity during the isolation procedures.
For the detection of alkali-labile phosphate the procedure of Nimmo et al. [11] was used. Portions (0-15 nmol) of dialysed C3 were precipitated by the addition of 10 % (w/v) trichloroacetic acid. A 1 mg portion of bovine serum albumin (Sigma Chemical Co.) was used as the zero phosphate control, and 0.3 mg of human fibrinogen (Imco, Stockholm, Sweden) containing about 1 nmol ofprotein-bound phosphate was used as a positive control. KH2PO4 (3 nmol) was added to the final supernatants for phosphate determination to ensure that all were within the 3-15 nmol detection range. Control experiments with albumin and fibrinogen showed that the addition of 3 nmol of phosphate improved the sensitivity of the test. All samples were in triplicate. Measurement of plasma ATP concentration
Heparinized whole blood was used in this experiment, as heparin inhibits the ATP release from blood cells during haemostasis [8] . The blood was centrifuged at 600g for 10 min and the platelet-rich plasma was removed. The plasma was then centrifuged twice at 1200 g to pellet the platelets, and the platelet-poor plasma, checked microscopically, was tested for the presence of ATP by the procedure of Ljungstr6m & Ekman [12] , except that 100000 c.p.m. of [y-32P]ATP was added to 27 ml of plasma to allow the calculation of the final recovery of ATP after chromatography on a Dowex 1-X8 column (2 ml). The peak was pooled and the absorbance at 260 nm was measured, with the fractions immediately before and after the peak being used as blank. A molar absorption coefficient of 14300 m-1 cm-' was used to calculate the ATP concentration. 
RESULTS

Plasma protein phosphorylation by endogenous kinases and ATP
Experiments to detect endogenous extracellular protein kinase activity in blood were carried out as described above and the results of one such experiment are shown in Fig. 1 [3] and [2] respectively. The position of C3a is shown to demonstrate that no complement activation had occurred.
Incubation of the blood at 37°C for periods of up to 30 min did not alter the pH of the blood (result not shown). The protein kinase activity appeared to be associated mainly with the erythrocyte fraction, but was also detected to a lesser extent when plasma alone was incubated with labelled ATP (result not shown).
In passing one may note the phosphorylation ofhuman albumin in Fig. 1 . Albumins from various species have previously been shown to be substrates for some protein kinases in vitro [13, 14] . This is the first time, however, that an albumin has been found to be phosphorylated under more physiological conditions. Immunoprecipitation of C3 from plasma and serum To prove conclusively that C3 can be phosphorylated in blood, it was decided to immunoprecipitate C3 from plasma and serum prepared from blood incubated with labelled ATP as described above and then to autoradiograph the gels obtained after SDS/polyacrylamide-gel electrophoresis. Complement S protein was chosen as a suitable control as it is a phosphoprotein and its peptide chain has a different Mr, 75000, to those of C3 a-chain, Mr 115000, and fl-chain, Mr 70000. The results portrayed in Fig. 2 show the 32P-labelled immunoprecipitated peptide chains seen on the autoradiogram. The a-chain of C3 is clearly visible in lanes I and 2, and it is apparent that there is another phosphorylated band of Mr 47000 in both lanes. This fragment arises from the N-terminal of the C3 a-chain upon the denaturation of C3 in SDS. Because of C3's unusual thioester bond, a proportion of the C3 molecules undergo hydrolysis of the peptide chain when denatured in SDS [15] . After Following these experiments, the possibility that C3 already contains protein-bound phosphate in vivo was investigated and the results are presented in Fig. 3 . This shows that the zero control bovine serum albumin contained 0.002+0.030mol of phosphate/mol of protein. Human C3 contained 0.156 + 0.064 mol of phosphate/mol of protein, and human fibrinogen, used here as a positive control, contained 0.833 + 0.122 mol of phosphate/mol of protein, which is in good agreement with the expected value of about 1 mol of phosphate/mol of protein.
Measurement of plasma ATP concentration
As a result of the 32P incorporation found in Figs. 1 and 2 experiments were undertaken to determine the free ATP concentration in human plasma, since it was believed that the amount of ATP added in those experiments was too small to account for the findings. After correction for losses during the purification the plasma concentration of ATP was found to be 2.25+ 0.3 /LM (mean of the results for three experiments).
DISCUSSION
There is a great deal known about regulatory phosphorylation of intracellular proteins and how it adds another layer of control on to metabolic regulation. Now, attention is shifting to the surface of cells and even extracellularly. The discoveries of soluble protein kinases in plasma [3, [5] [6] [7] , protein phosphorylation in plasma [2, 6, 7, 16] and that the free ATP concentration in serum reaches 20 ftM during coagulation [8] all suggest that protein phosphorylation plays a regulatory role in the blood. To test this hypothesis, I investigated whether C3 was, or could be, phosphorylated. As the target protein of both the classical and alternative pathways, triggering the amplification mechanism that leads to the production of the cytotoxic membrane attack complexes, it requires close control.
When carrier-free [y-32P]ATP was added to EDTAanticoagulated whole human blood, three main protein bands were phosphorylated, as shown in Fig. 1 . The bands were tentatively identified as albumin, complement S protein and the a-chain of C3. Fig. 2 confirmed that the ac-chain of C3 was phosphorylated in anticoagulated blood incubated with labelled ATP. Further, that it was also phosphorylated to a lesser extent (620 of the plasma value) in clotting blood. Complement S protein was about twice as heavily labelled as C3 in the plasma tracks and, unlike C3, the incorporation was as high in clotting blood as in anticoagulated blood. This difference between plasma and serum may have some regulatory significance. When acted upon by the C3 convertase, a small peptide (C3a) is cleaved off the N-terminus of the ac-chain. This peptide is contained within the 47000-Mr fragment seen to be phosphorylated in Fig. 2 [2] to be phosphorylated in plasma, but an incubation time of 3 h and the addition of the non-physiological Mn2" ion at a concentration of ldmM was required. In the present paper it is shown that, if whole blood was used for the phosphorylation, an almost 5-fold higher incorporation was achieved (by comparison with data given in ref. [2] ) and without the addition of bivalent cations such as Mg2" and Mn2+.
The detection of alkali-labile phosphate in C3 shows that C3 is a phosphoprotein in vivo. Although the degree of phosphorylation appears modest at 0.15 mol/mol of protein, the values are significantly above those for bovine serum albumin and are most likely underestimates as a consequence of phosphatase activity during preparation. Further, although fibrinogen appears to be stoichiometrically phosphorylated, the 1 mol of phosphate/mol of protein is distributed over at least six different serine residues in the two Aa-chains [17] . 
